The Obama administration’s decision to reverse restrictions on embryonic stem cell research funding was a hard-earned victory for the many associations who lobbied hard for such a change. Now industry, medical and university groups all expect their members to benefit. At the moment, all eyes are on the National Institutes of Health, set to release the final version of funding guidelines July 7. The new policy will lift some of the restrictions imposed by the Bush administration, which severely limited federal funding for human embryonic stem cell research. The lobbying effort began back in 2001, when a range of associations joined forces with universities, scientific… Read More